Certified Leader in Sterile
IV Solutions Export
Product Portfolio for Export
Ateco Pharma specializes in producing a wide range of sterile I.V. solutions using Blow-Fill-Seal (BFS) technology to ensure maximum sterility, safety, and precision.
All products are manufactured under GMP and ISO-certified standards, with flexible pack sizes tailored to meet the needs of hospitals, clinics, and distributors worldwide.
About Our Export Operations
Located in the Egypt Suez Canal Economic Zone (SCZone – Ain Sokhna), Ateco Pharma is a GMP- and ISO-certified manufacturer specializing in sterile I.V. solutions produced using advanced Blow-Fill-Seal (BFS) technology.
Since beginning operations in late 2022, our facility has been dedicated to meeting local healthcare needs while serving as a strategic export hub for international markets across Africa, the Middle East, and beyond.
Every product leaving our facility reflects Ateco’s commitment to global quality standards, regulatory compliance, and customer trust.
Our Global Commitment
Ateco continues to expand its presence in
Africa, the Middle East, Asia, and Latin America,
partnering with trusted distributors who share our passion for quality and innovation.
Packaging & Shipping
Ateco ensures every product is packed and shipped according to international pharmaceutical standards.
Our export packaging is tamper-proof, barcoded, and labeled for multilingual markets, ensuring safety and traceability across all shipments.
Key Features
- Lead time: 4–6 weeks after artwork approval
- Shipping terms: EXW • FOB • CIF • DAP
- Reliable logistics—delivering on time, every time.

Become a Global Partner
Join Ateco’s growing network of international distributors and healthcare partners. We are dedicated to building long-term collaborations based on quality, trust, and transparency. Our export team supports partners through every stage — from product selection to registration and logistics — ensuring seamless market entry and sustainable success.
Together, we deliver reliable healthcare solutions to patients worldwide.




